U.S. shares lower at close of trade Dow Jones Industrial Average ... - Investing.com UK
| MKKGY Stock | USD 29.90 0.04 0.13% |
Slightly above 62% of Merck KGaA's investor base is looking to short. The analysis of overall sentiment of trading Merck KGaA ADR pink sheet suggests that many investors are alarmed at this time. Merck KGaA's investing sentiment can be driven by a variety of factors including economic data, Merck KGaA's earnings reports, geopolitical events, and overall market trends.
Merck |
U.S. shares lower at close of trade Dow Jones Industrial Average ... Investing.com UK
Read at news.google.com
 |
Merck KGaA Fundamental Analysis
We analyze Merck KGaA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck KGaA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck KGaA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Merck KGaA is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Merck KGaA ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Merck KGaA pink sheet to make a market-neutral strategy. Peer analysis of Merck KGaA could also be used in its relative valuation, which is a method of valuing Merck KGaA by comparing valuation metrics with similar companies.
Peers
Merck KGaA Related Equities
| AKAN | Akanda Corp | 2.94 | ||||
| COLL | Collegium Pharmaceutical | 0.68 | ||||
| EOLS | Evolus | 0.80 | ||||
| INCR | INC Research | 1.48 | ||||
| ANIP | ANI Pharmaceuticals | 3.64 | ||||
| YCBD | CbdMD | 3.92 | ||||
| BFRI | Biofrontera | 9.09 |
Additional Tools for Merck Pink Sheet Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.